Cochrane Abstracts
Tamoxifen or letrozole versus standard methods for women with estrogen‐receptor positive breast cancer undergoing oocyte or embryo cryopreservation in assisted reproduction
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Tamoxifen or Letrozole Versus Standard Methods for Women With Estrogen‐receptor Positive Breast Cancer Undergoing Oocyte or Embryo Cryopreservation in Assisted Reproduction." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435089/all/Tamoxifen_or_letrozole_versus_standard_methods_for_women_with_estrogen‐receptor_positive_breast_cancer_undergoing_oocyte_or_embryo_cryopreservation_in_assisted_reproduction.
Tamoxifen or letrozole versus standard methods for women with estrogen‐receptor positive breast cancer undergoing oocyte or embryo cryopreservation in assisted reproduction. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435089/all/Tamoxifen_or_letrozole_versus_standard_methods_for_women_with_estrogen‐receptor_positive_breast_cancer_undergoing_oocyte_or_embryo_cryopreservation_in_assisted_reproduction. Accessed February 8, 2026.
Tamoxifen or letrozole versus standard methods for women with estrogen‐receptor positive breast cancer undergoing oocyte or embryo cryopreservation in assisted reproduction. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435089/all/Tamoxifen_or_letrozole_versus_standard_methods_for_women_with_estrogen‐receptor_positive_breast_cancer_undergoing_oocyte_or_embryo_cryopreservation_in_assisted_reproduction
Tamoxifen or Letrozole Versus Standard Methods for Women With Estrogen‐receptor Positive Breast Cancer Undergoing Oocyte or Embryo Cryopreservation in Assisted Reproduction [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 February 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435089/all/Tamoxifen_or_letrozole_versus_standard_methods_for_women_with_estrogen‐receptor_positive_breast_cancer_undergoing_oocyte_or_embryo_cryopreservation_in_assisted_reproduction.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Tamoxifen or letrozole versus standard methods for women with estrogen‐receptor positive breast cancer undergoing oocyte or embryo cryopreservation in assisted reproduction
ID - 435089
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435089/all/Tamoxifen_or_letrozole_versus_standard_methods_for_women_with_estrogen‐receptor_positive_breast_cancer_undergoing_oocyte_or_embryo_cryopreservation_in_assisted_reproduction
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
